Pacer Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $209M | Sell |
2,450,460
-148,594
| -6% | -$13.2M | 0.59% | 41 |
|
|
2025
Q4 | $205M | Sell |
2,599,054
-97,993
| -4% | -$7.68M | 0.52% | 46 |
|
|
2025
Q3 | $216M | Buy |
2,697,047
+2,611,485
| +3,052% | +$223M | 0.54% | 44 |
|
|
2025
Q2 | $7.78M | Buy |
85,562
+27,307
| +47% | +$2.49M | 0.02% | 563 |
|
|
2025
Q1 | $5.46M | Sell |
58,255
-31,595
| -35% | -$2.83M | 0.01% | 608 |
|
|
2024
Q4 | $8.17M | Sell |
89,850
-21,422
| -19% | -$2.04M | 0.02% | 501 |
|
|
2024
Q3 | $11.6M | Buy |
111,272
+17,623
| +19% | +$1.8M | 0.02% | 436 |
|
|
2024
Q2 | $9.09M | Sell |
93,649
-597
| -0.6% | -$55.1K | 0.02% | 456 |
|
|
2024
Q1 | $8.49M | Sell |
94,246
-22,998
| -20% | -$1.95M | 0.02% | 462 |
|
|
2023
Q4 | $9.35M | Buy |
117,244
+41,731
| +55% | +$3.14M | 0.03% | 418 |
|
|
2023
Q3 | $5.37M | Buy |
75,513
+1,304
| +2% | +$97.5K | 0.02% | 455 |
|
|
2023
Q2 | $5.72M | Buy |
74,209
+13,135
| +22% | +$1.02M | 0.02% | 506 |
|
|
2023
Q1 | $4.59M | Sell |
61,074
-108,209
| -64% | -$8.05M | 0.02% | 558 |
|
|
2022
Q4 | $13.3M | Buy |
169,283
+136,353
| +414% | +$10.2M | 0.07% | 229 |
|
|
2022
Q3 | $2.31M | Sell |
32,930
-102,411
| -76% | -$8.03M | 0.02% | 421 |
|
|
2022
Q2 | $10.8M | Buy |
135,341
+92,018
| +212% | +$7.2M | 0.08% | 210 |
|
|
2022
Q1 | $3.29M | Sell |
43,323
-9,456
| -18% | -$749K | 0.03% | 502 |
|
|
2021
Q4 | $4.5M | Sell |
52,779
-47,814
| -48% | -$3.73M | 0.05% | 499 |
|
|
2021
Q3 | $7.6M | Buy |
100,593
+23,678
| +31% | +$1.88M | 0.1% | 248 |
|
|
2021
Q2 | $6.26M | Buy |
76,915
+30,386
| +65% | +$2.48M | 0.09% | 293 |
|
|
2021
Q1 | $3.67M | Sell |
46,529
-6,841
| -13% | -$536K | 0.06% | 324 |
|
|
2020
Q4 | $4.56M | Sell |
53,370
-17,279
| -24% | -$1.43M | 0.09% | 193 |
|
|
2020
Q3 | $5.45M | Sell |
70,649
-13,638
| -16% | -$1.04M | 0.12% | 138 |
|
|
2020
Q2 | $6.17M | Buy |
+84,287
| New | +$5.99M | 0.13% | 129 |
|
|
2020
Q1 | – | Sell |
-97,989
| Closed | -$6.75M | – | 746 |
|
|
2019
Q4 | $6.75M | Sell |
97,989
-1,454
| -1% | -$99.1K | 0.3% | 53 |
|
|
2019
Q3 | $7.31M | Buy |
99,443
+11,956
| +14% | +$867K | 0.16% | 107 |
|
|
2019
Q2 | $6.27M | Buy |
87,487
+4,402
| +5% | +$312K | 0.15% | 109 |
|
|
2019
Q1 | $5.69M | Buy |
+83,085
| New | +$5.37M | 0.16% | 107 |
|
|
2018
Q4 | – | Sell |
-46,771
| Closed | -$3.13M | – | 634 |
|
|
2018
Q3 | $3.13M | Buy |
46,771
+6,194
| +15% | +$413K | 0.12% | 164 |
|
|
2018
Q2 | $2.63M | Buy |
40,577
+6,820
| +20% | +$446K | 0.12% | 175 |
|
|
2018
Q1 | $2.42M | Buy |
33,757
+5,445
| +19% | +$392K | 0.13% | 151 |
|
|
2017
Q4 | $2.14M | Buy |
28,312
+5,982
| +27% | +$437K | 0.15% | 135 |
|
|
2017
Q3 | $1.63M | Buy |
22,330
+2,106
| +10% | +$152K | 0.14% | 112 |
|
|
2017
Q2 | $1.5M | Buy |
20,224
+1,566
| +8% | +$116K | 0.15% | 109 |
|
|
2017
Q1 | $1.37M | Buy |
18,658
+1,123
| +6% | +$78.6K | 0.17% | 85 |
|
|
2016
Q4 | $1.15M | Buy |
17,535
+351
| +2% | +$24.1K | 0.16% | 86 |
|
|
2016
Q3 | $1.27M | Sell |
17,184
-102
| -0.6% | -$7.54K | 0.19% | 72 |
|
|
2016
Q2 | $1.26M | Buy |
17,286
+1,442
| +9% | +$103K | 0.2% | 75 |
|
|
2016
Q1 | $1.12M | Sell |
15,844
-2
| -0% | -$133 | 0.25% | 78 |
|
|
2015
Q4 | $1.06M | Buy |
+15,846
| New | +$1.05M | 0.25% | 80 |
|
|
2013
Q4 | $597K | Buy |
+8,634
| New | +$553K | 0.14% | 194 |
|
Other funds holding CL
VCM
DAM
VPM
Pacer Advisors's CL Position: Q1 2026 in Review
Pacer Advisors reduced its Colgate-Palmolive (CL) stake by 5.7% in Q1 2026, selling an estimated $13.2M and leaving 2,450,460 shares worth $209M. The position accounts for 0.59% of the portfolio, ranked #41.
Pacer Advisors first reported a position in CL in Q4 2013 and has held it in 41 quarters since. The position peaked at $216M in Q3 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Pacer Advisors held 2,450,460 shares of Colgate-Palmolive worth $209M as of Q1 2026.
- Pacer Advisors sold 148,594 Colgate-Palmolive shares in Q1 2026, an estimated $13.2M.
- Colgate-Palmolive made up 0.59% of Pacer Advisors's portfolio in Q1 2026, its #41 holding.
- Pacer Advisors first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 41 quarters since.
- Pacer Advisors's Colgate-Palmolive position peaked at $216M in Q3 2025.
- 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.